Back to search
FDAFDA · Food and drugs·Recall number D-1167-2014

Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10

Published March 26, 2014 · Recall initiated: March 3, 2014

Summary

FDA records drug Class III recall D-1167-2014, published March 26, 2014 and initiated March 3, 2014. Recalling firm: McKesson Packaging Services; Status: Terminated; Reported quantity: 1,557 Boxes; Lot: Lot #: 91357. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
McKesson Packaging Services
Distributor
Nationwide
Lot
Lot #: 91357
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10 recalled?

Yes. FDA published recall D-1167-2014 on March 26, 2014. Reported hazard: Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.

What should I do if I have this product?

Voluntary: Firm initiated · Letter